News

Press ReleaseNetwork established to identify opportunities for regulation to support innovation within advanced therapies
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Regulatory News - May 2021Regulatory News - May 2021Press release: FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technologyPress release: FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technologyRinri Therapeutics secures Innovate UK funding grant for £3.2m project to advance its novel cell-based therapy to restore hearing lossRinri Therapeutics secures Innovate UK funding grant for £3.2m project to advance its novel cell-based therapy to restore hearing lossRoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training NetworkRoslinCT has been selected as the second National Training Centre in the Advanced Therapies Skills Training NetworkRegulatory News - April 2021Regulatory News - April 2021ATTC network establishes first Advanced Therapies NHS Readiness ToolkitATTC network establishes first Advanced Therapies NHS Readiness ToolkitRegulatory news - March 2021Regulatory news - March 2021March newsletter: UK attractiveness for ATMP companies to expand their operationsMarch newsletter: UK attractiveness for ATMP companies to expand their operationsNational Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)National Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)April news: The UK attractiveness for companies to expand their ATMP operationsApril news: The UK attractiveness for companies to expand their ATMP operationsPress release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenagePress release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenageRegulatory news - February 2021Regulatory news - February 2021